ZFIN ID: ZDB-FISH-150901-13355
Fish name: lamc1ti263a/ti263a
Genotype: lamc1ti263a/ti263a
Targeting Reagent: none
HUMAN DISEASE MODELED by lamc1ti263a/ti263a
No data available
GENE EXPRESSION
Gene expression in lamc1ti263a/ti263a
Reporter gene expression No data available
PHENOTYPE
Phenotype in lamc1ti263a/ti263a
Phenotype Conditions Figures
anterior/posterior axon guidance process quality, abnormal standard conditions Table 1 from Karlstrom et al., 1996
axon extension process quality, abnormal standard conditions Fig. 8 with image from Odenthal et al., 1996
axon guidance process quality, abnormal standard conditions Table 1 from Jiang et al., 1996
brain disorganized, abnormal standard conditions Fig. 8 with image from Odenthal et al., 1996
brain morphology, abnormal standard conditions Table 1 from van Eeden et al., 1996
brain quality, abnormal standard conditions Fig. for (ti263a) from Phenotype Annotation (1994-2006)
brain surface feature shape, abnormal standard conditions Table 1 from Jiang et al., 1996
cranial nerve II morphology, abnormal standard conditions Fig. 1 from Biehlmaier et al., 2007
detection of light stimulus involved in visual perception arrested, abnormal standard conditions Fig. 7 from Biehlmaier et al., 2007
eye quality, abnormal standard conditions Fig. for (ti263a) from Phenotype Annotation (1994-2006)
fast muscle cell 2-D shape, normal control Fig. 2 with image from Peterson et al., 2010
fast muscle cell circular, abnormal chemical treatment: Cyclopamine Fig. 2 with image from Peterson et al., 2010
fast muscle cell decreased length, abnormal chemical treatment: Cyclopamine Fig. 2 with image from Peterson et al., 2010
fast muscle cell length, normal control Fig. 2 with image from Peterson et al., 2010
fast muscle cell muscle tendon junction ab2-fn labeling increased amount, abnormal control Fig. 2 with image from Jenkins et al., 2016
hindbrain morphology, abnormal standard conditions Table 1 from Jiang et al., 1996
hindbrain quality, abnormal standard conditions Fig. for (ti263a) from Phenotype Annotation (1994-2006)
lens decreased size, abnormal standard conditions Fig. 1 from Biehlmaier et al., 2007
Mauthner neuron axon mislocalised medially, abnormal standard conditions Fig. 8 with image from Odenthal et al., 1996
muscle cell fate specification occurrence, normal control Fig. 1 with image from Peterson et al., 2010
muscle cell fate specification occurrence, normal chemical treatment: Cyclopamine Fig. 1 with image from Peterson et al., 2010
muscle organ morphogenesis delayed, abnormal control Fig. 1 with image from Peterson et al., 2010
muscle organ morphogenesis delayed, abnormal chemical treatment: Cyclopamine Fig. 1 with image from Peterson et al., 2010
muscle tissue development disrupted, abnormal standard conditions Fig. 2 with image from Goody et al., 2010
myotome Ab1-mmp11 labeling increased amount, abnormal control Fig. 3 with image from Jenkins et al., 2016
myotome ab2-fn labeling increased amount, abnormal control Fig. 6 with image from Jenkins et al., 2016
myotome U-shaped, abnormal standard conditions Fig. 1 with image from Goody et al., 2010
myotome muscle tendon junction ab2-fn labeling decreased amount, abnormal control Fig. 6 with image from Jenkins et al., 2016
myotome muscle tendon junction ab2-fn labeling increased amount, abnormal control Fig. 6 with image from Jenkins et al., 2016
myotome muscle tendon junction Ab1-mmp11 labeling spatial pattern, abnormal control Fig. 3 with image from Jenkins et al., 2016
nervous system quality, abnormal standard conditions Fig. for (ti263a) from Phenotype Annotation (1994-2006)
notochord decreased thickness, abnormal standard conditions Fig. 8 with image from Odenthal et al., 1996
notochord poorly differentiated, abnormal standard conditions Table 1 from Jiang et al., 1996
notochord quality, abnormal standard conditions Fig. for (ti263a) from Phenotype Annotation (1994-2006)
notochord structure, abnormal standard conditions Fig. 8 with image from Odenthal et al., 1996
notochord undifferentiated, abnormal standard conditions Table 1 from van Eeden et al., 1996
notochord development quality, abnormal standard conditions Fig. for (ti263a) from Phenotype Annotation (1994-2006)
optokinetic behavior decreased rate, abnormal standard conditions Fig. 6 from Biehlmaier et al., 2007
retinal ganglion cell axon ipsilateral to eye, abnormal standard conditions Table 1 from Karlstrom et al., 1996
retinal ganglion cell axon misrouted, abnormal standard conditions Table 1 from Karlstrom et al., 1996
retinal ganglion cell layer dispersed, abnormal standard conditions Fig. 1 from Biehlmaier et al., 2007
retinal photoreceptor layer decreased thickness, abnormal standard conditions Fig. 1 from Biehlmaier et al., 2007
segmentation occurrence, normal control Fig. 1 with image from Peterson et al., 2010
segmentation occurrence, normal chemical treatment: Cyclopamine Fig. 1 with image from Peterson et al., 2010
sensory system quality, abnormal standard conditions Fig. for (ti263a) from Phenotype Annotation (1994-2006)
slow muscle cell decreased amount, abnormal chemical treatment: Cyclopamine Fig. 3 with image from Peterson et al., 2010
slow muscle cell degenerate, abnormal control Fig. 6 with image from Jenkins et al., 2016
slow muscle cell detached from slow muscle cell, abnormal control Fig. 6 with image from Jenkins et al., 2016
somite condensed, abnormal standard conditions Table 1 from van Eeden et al., 1996
somite disorganized, abnormal chemical treatment: Cyclopamine Fig. 1 with image from Peterson et al., 2010
somite quality, abnormal standard conditions Fig. for (ti263a) from Phenotype Annotation (1994-2006)
somite border present, normal chemical treatment: Cyclopamine Fig. 1 with image from Peterson et al., 2010
somite border present, normal control Fig. 1 with image from Peterson et al., 2010
somite specification occurrence, normal control Fig. 1 with image from Peterson et al., 2010
somite specification occurrence, normal chemical treatment: Cyclopamine Fig. 1 with image from Peterson et al., 2010
whole organism fn1b expression increased amount, abnormal control Fig. 2 with image from Jenkins et al., 2016
whole organism ab2-fn labeling increased amount, abnormal control Fig. 2 with image from Jenkins et al., 2016
whole organism lethal (sensu genetics), abnormal standard conditions Fig. for (ti263a) from Phenotype Annotation (1994-2006)
whole organism viability, abnormal standard conditions Table 1 from Karlstrom et al., 1996

CITATIONS  (14)